Xcout Intel
MgShell
MgShell is a preclinical-stage biotechnology and drug delivery company focused on developing magnesium-based drug delivery systems. The company is headquartered in Milan, Italy.
Subscribe to see MgShell’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
MgShell at a glance
MgShell is a medtech company headquartered in Italy. Its most recent funding round, Seed, raised $1.3M in April 2025. Xcout tracks 9 named people at MgShell, including Marco Ferroni (CEO).
MgShell leadership
- Marco FerroniCEO
- Vera ScuderiCOO
- Marco Ferronico-founder & CEO
- Francesco De Gaetanoco-founder & CTO
- Francesco De GaetanoResearcher
- Enrico Gianottimember of the board
3 more named people on record for MgShell, with roles, board committees and tenure — see the full roster →
MgShell funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $1.3M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
MgShell competitors
A few of MgShell's closest competitors — see the full list of competitors and alternatives →
Mana.bio is an AI-based drug delivery startup headquartered in Tel Aviv, Israel, focusing on gene therapy and lipid nanoparticle development for mRNA and oligonucleotide therapeutics. The company leverages artificial intelligence to create advanced platforms for next-generation vaccines and genetic medicines.
Generare is a biotechnology and artificial intelligence company headquartered in Paris, France, focused on commercial bioprospecting and decoding natural products.
IAMA Therapeutics is a clinical-stage pharmaceutical and biotechnology company founded in 2021 and headquartered in Genoa, Italy. The firm is dedicated to researching and developing innovative, disease-modifying medicines to treat brain disorders.
Founded in 2021 and headquartered in Shenzhen, China, MagicRNA Biotechnology Co., Ltd. is a clinical-stage biotechnology company focused on nucleic acid drug delivery and the research and development of next-generation mRNA and lipid nanoparticle technologies for the treatment of cancer and infectious diseases.
LUCA Science is a pre-clinical stage biotechnology company that develops functional mitochondria as therapeutic agents to treat damaged tissues and organs. The company utilizes a proprietary method to isolate functional mitochondria, combining it with advanced drug delivery and formulation technology to create storable biopharmaceutical agents.
Get MgShell's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on MgShell in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access